Brain and Behavior Pt.2
Classification of Drugs
Overview of Drug Classes
All drugs are not the same; they can be categorized into various classes based on their effects and properties. These classes include:
Stimulants
Depressants
Hallucinogens
Narcotics
Marijuana/Cannabis (often classified separately)
Stimulants
Properties
Increased arousal
Increased activity
Suppressed appetite
Common Examples
Illegal Stimulants: Cocaine, Amphetamines
Legal Stimulants: Caffeine, Nicotine
Unique Case - MDMA
MDMA (Ecstasy) possesses both stimulant-like properties and hallucinogenic effects, categorizing it under multiple drug classes.
Depressants
Properties
Reduce arousal and activity
Dampen mood
Overall reduction of anxiety
Common Examples
Most Utilized and Abused Depressant: Alcohol
Initial effects of alcohol may include increased energy and sociability due to disinhibition; however, with increased consumption, depressant effects become prominent, leading to reduced arousal and activity.
Other Common Depressants:
Benzodiazepines (e.g., Valium, Xanax)
Hallucinogens
Properties
Produce altered states of consciousness, including sensory distortion and introspection.
Historically used for spiritual journeys or vision quests.
Common Examples
LSD (Acid)
Psilocybin (Magic Mushrooms)
DMT (Dimethyltryptamine) - noted for being highly potent
MDMA, also has properties of this class due to its hallucinogenic effects.
Narcotics
Properties
Provide significant pain relief.
Induce states of introversion and suppress cardiac functions.
Common Examples
Legal Narcotics: Morphine, Vicodin, Percocet, Fentanyl
Illicit Narcotics: Heroin, Opium
Marijuana/Cannabis
Unique Properties
Acts on both excitatory and inhibitory systems of the nervous system.
Stimulates appetite and provides pain relief.
Advocated for medicinal use in various diseases (e.g., multiple sclerosis).
Can be consumed in various forms, including raw plant, hashish, and other preparations.
Drug Properties and Abuse
Rewarding Properties of Drugs
Fundamental reason behind drug consumption relates to the rewarding properties of drugs at the nervous system level.
Neurochemical Explanation:
All rewarding drugs act on the dopamine system, with dopamine released across the brain from midbrain nuclei, leading to reinforcement in behavior.
Behavioral Explanation:
In animal models (e.g., rats), willingness to work for food or drugs is a measure of reward. B.F. Skinner developed the Skinner Box experiment to understand this relationship.
Rats pressing a lever for food rewards can be adapted to test for drug reward by comparing known reinforcing drugs like cocaine or heroin against new drugs.
Importance of Characterizing Reward
Understanding drug reward is critical for assessing abuse liability.
Drugs found to be rewarding in animal models show higher abuse potential.
Drugs within classes such as stimulants, depressants, and narcotics are typically characterized by high abuse potential (e.g., amphetamines, cocaine, benzodiazepines, alcohol, heroin, and opium).
Lower Abuse Potential
Hallucinogens and marijuana are generally associated with lower abuse potential compared to stimulants, depressants, and narcotics. This does not rule out their abuse, but suggests less likelihood of compulsive use or self-administration at high quantities.
Implications for Legality and Regulation
Historically, drug use has faced significant legislation efforts, often perceived as conservative or puritanical.
Example: The Marijuana Tax Stamp Act was originally passed but later ruled unconstitutional.
The establishment of the Drug Enforcement Administration and regulatory measures occurred under President Richard Nixon.
Currently, there are ongoing debates about drug access and regulations, particularly around medicinal marijuana, balancing individual freedoms against public health concerns.
Conclusion
In summary, we have discussed the classifications of drugs, their properties, differences in abuse potential, and implications for legality and regulation. Understanding these elements is crucial for further studies in pharmacology and public health policy regarding drug use.